(Q53656255)

16 May 2018

reason for preferred rank

title

HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions☆ (English)

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(02)00069-0

27 December 2023

HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12713982

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(02)00069-0

27 December 2023

author name string

Chan Joo Kim

1

1 reference

16 May 2018

Jeongmi Kim Jeong

2

1 reference

16 May 2018

Misun Park

3

1 reference

16 May 2018

Tae Shin Park

4

1 reference

16 May 2018

Tae Chul Park

5

1 reference

16 May 2018

Sung Eun Namkoong

6

1 reference

16 May 2018

Jong Sup Park

7

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

16 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0090825802000690?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(02)00069-0

https://api.elsevier.com/content/article/PII:S0090825802000690?httpAccept=text/plain

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(02)00069-0

27 December 2023

1 reference

16 May 2018

volume

89

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

210-217

1 reference

16 May 2018

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Detection of human papillomavirus genotypes in cervical neoplasia from Korean women using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Possible prognostic significance of human papillomavirus type in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Cervical Cytology Practice Guidelines. American Society of Cytopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

A population-based five-year follow-up study of cervical human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Light-generated oligonucleotide arrays for rapid DNA sequence analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Universal DNA microarray method for multiplex detection of low abundance point mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Risk factors for rapid-onset cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

HPV testing in primary screening of older women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Human papillomavirus testing in primary cervical screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Behavior of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Human papillomavirus and cancer: the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Human papillomavirus testing for primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Benefits and costs of using HPV testing to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900069-0

7 January 2021

medical guideline

10

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(02)00069-0

27 December 2023

Identifiers

1 reference

16 May 2018

1 reference

16 May 2018